Page last updated: 2024-10-22

amodiaquine and HbS Disease

amodiaquine has been researched along with HbS Disease in 3 studies

Amodiaquine: A 4-aminoquinoline compound with anti-inflammatory properties.
amodiaquine : A quinoline having a chloro group at the 7-position and an aryl amino group at the 4-position.

Research Excerpts

ExcerptRelevanceReference
"Children with sickle cell anemia (SCA) in areas of Africa with endemic malaria transmission are commonly prescribed malaria chemoprevention."7.11Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial. ( Clapp, S; Freedman, B; Green, CL; Kirui, JK; Korwa, S; Njuguna, FM; O'Meara, WP; Taylor, SM; Wu, A, 2022)
"Children with sickle cell anemia (SCA) in areas of Africa with endemic malaria transmission are commonly prescribed malaria chemoprevention."3.11Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial. ( Clapp, S; Freedman, B; Green, CL; Kirui, JK; Korwa, S; Njuguna, FM; O'Meara, WP; Taylor, SM; Wu, A, 2022)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Taylor, SM1
Korwa, S1
Wu, A1
Green, CL1
Freedman, B1
Clapp, S1
Kirui, JK1
O'Meara, WP1
Njuguna, FM1
Adjei, GO1
Goka, BQ1
Enweronu-Laryea, CC1
Rodrigues, OP1
Renner, L1
Sulley, AM1
Alifrangis, M1
Khalil, I1
Kurtzhals, JA1
Ndounga, M1
Casimiro, PN1
Koukouikila-Koussounda, F1
Bitemo, M1
Diassivy Matondo, B1
Ndounga Diakou, LA1
Basco, LK1
Ntoumi, F1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Enhancing Preventive Therapy of Malaria In Children With Sickle Cell Anemia in East Africa (EPiTOMISE)[NCT03178643]Phase 4246 participants (Actual)Interventional2018-01-23Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

3 trials available for amodiaquine and HbS Disease

ArticleYear
Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial.
    PLoS medicine, 2022, Volume: 19, Issue:10

    Topics: Amodiaquine; Anemia, Sickle Cell; Antimalarials; Artemisinins; Chemoprevention; Child; Child, Presch

2022
A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine in Ghanaian paediatric sickle cell and non-sickle cell disease patients with acute uncomplicated malaria.
    Malaria journal, 2014, Sep-19, Volume: 13

    Topics: Amodiaquine; Anemia, Sickle Cell; Antimalarials; Artemether; Artemisinins; Blood Cell Count; Child;

2014
Artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in Congolese children under 10 years old living in a suburban area: a randomized study.
    Malaria journal, 2015, Oct-29, Volume: 14

    Topics: Amodiaquine; Anemia, Sickle Cell; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisi

2015